Login to Your Account



FDA Raises Endpoint Concerns in Study of Salix Liver Drug

By Donna Young


Tuesday, February 23, 2010
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription